Deer antler base as a traditional Chinese medicine: A review of its traditional uses, chemistry and pharmacology

被引:151
作者
Wu, Feifei [1 ,2 ]
Li, Huaqiang [1 ,2 ]
Jin, Liji [1 ,2 ]
Li, Xiaoyu [1 ,2 ]
Ma, Yongsheng [3 ]
You, Jiansong [1 ,2 ,4 ]
Li, Shuying [4 ]
Xu, Yongping [1 ,2 ,4 ,5 ]
机构
[1] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Peoples R China
[2] Dalian Univ Technol, Ctr Food Safety Anim Origin, Minist Educ, Dalian 116620, Peoples R China
[3] Dalian Ocean Univ, Coll Food Sci & Engn, Dalian 116023, Peoples R China
[4] Dalian SEM Bioengn Technol Co Ltd, Dalian 116620, Peoples R China
[5] Dalian Univ Technol, State Key Labs Fine Chem, Dalian 116012, Peoples R China
基金
中国国家自然科学基金;
关键词
Deer antler base; Local and traditional uses; Chemical constituents; Pharmacology; Clinical trials; NF-KAPPA-B; DIFFERENTIATION; PROLIFERATION; INHIBITION; CELLS; L;
D O I
10.1016/j.jep.2012.12.008
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Deer antler base (Cervus, Lu Jiao Pan) has been recorded in the Chinese medical classics Shen Nong Ben Coo Jing 2000 years ago and is believed to nourish the Yin, tonify the kidney, invigorate the spleen, strengthen bones and muscles, and promote blood flow. In China, deer antler base has been extensively used in traditional Chinese medicine (TCM) to treat a variety of diseases including mammary hyperplasia, mastitis, uterine fibroids, malignant sores and children's mumps. Aim of the review: We provide an up-to-date and comprehensive overview of the traditional uses, chemistry, pharmacology, toxicology and clinical trials of deer antler base in order to explore its therapeutic potentials and future research needs. Background and methods: The pharmacological value of deer antler base was ignored for many years while researchers concentrated on the pharmacological value of velvet antler. However, more recently, scientists have carried out a great number of chemical, pharmacological and clinical studies on deer antler base. The present review covers the literature available from 1980 to 2012. All relevant information on deer antler base was collected from ancient Chinese herbal classics, pharmacopoeias, formularies, scientific journals, books, theses and reports via a library and electronic search by using PubMed, Google Scholar, Web of Science, Science Direct, and CNKI (in Chinese). Key findings: Both in vitro and in vivo pharmacological studies have demonstrated that deer antler base possess immunomodulatory, anti-cancer, anti-fatigue, anti-osteoporosis, anti-inflammatory, analgesic, antibacterial, anti-viral, anti-stress, anti-oxidant, hypoglycemic, hematopoietic modulatory activities and the therapeutic effect on mammary hyperplasia. Although the mechanism of actions is still not clear, the pharmacological activities could be mainly attributed to the major bioactive compounds amino acids, polypeptides and proteins. Based on animal studies and clinical trials, deer antler base causes no severe side effects. Conclusions: Deer antler base has emerged as a good source of traditional medicine. However, further investigations are needed to explore individual bioactive compounds responsible for these in vitro and in vivo pharmacological effects and its mechanism of actions. Further safety assessments and clinical trials in humans need to be performed before it can be integrated into medicinal practices. The present review has provided preliminary information for further studies and commercial exploitations of deer antler base. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:403 / 415
页数:13
相关论文
共 93 条
  • [1] [Anonymous], HDB COMPOSITION PHAR
  • [2] Bao H. Y., 1995, J JILIN AGR U, V17, P96
  • [3] The comparative pathology of human and mouse mammary glands
    Cardiff, RD
    Wellings, SR
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1999, 4 (01) : 105 - 122
  • [4] Effects of Gekko sulfated polysaccharide-protein complex on human hepatoma SMMC-7721 cells: Inhibition of proliferation and migration
    Chen, Dan
    Yao, Wei-Juan
    Zhang, Xiao-Lan
    Han, Xiao-Qiang
    Qu, Xiao-Yuan
    Ka, Wei-Bo
    Sun, Da-Gong
    Wu, Xiong-Zhi
    Wen, Zong-Yao
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2010, 127 (03) : 702 - 708
  • [5] Chen H. J., 2012, CURRENT SITUATION DE
  • [6] Chen Y. S., 1987, CHINESE J BIOCH PHAR, V2, P12
  • [7] Chen Y. S., 1989, SPECIAL WILD EC ANIM, V4, P9
  • [8] Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-κB signaling pathways
    Choi, Hwa Jung
    Park, Young Ran
    Nepal, Manoj
    Choi, Bo-Yun
    Cho, Nam-Pyo
    Choi, Seoung Hwan
    Heo, Soo Rye
    Kim, Hyung Sup
    Yang, Moon-Sik
    Soh, Yunjo
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 636 (1-3) : 28 - 35
  • [9] Dong Y. H., 1993, State Intellectual Property Office of the People's Republic of China, Patent Application, Patent No. 93112084
  • [10] Fan Y. L., 1997, State Intellectual Property Office of the People's Republic of China, Patent Application, Patent No. [97102756.0, 971027560]